New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
08:34 EDTAMAG, KERXKeryx appoints Appoints Greg Madison as COO
Keryx Biopharmaceuticals (KERX) announced the appointment of Greg Madison as executive vice president and COO. Madison joins the company from AMAG Pharmaceuticals (AMAG), where he served as the executive vice president and Chief Commercial Officer.
News For KERX;AMAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2015
10:00 EDTAMAGOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:20 EDTAMAGAMAG Pharmaceuticals transferred with a Market Perform at FBR Capital
FBR Capital transferred coverage of AMAG Pharmaceuticals with a Market Perform rating, a downgrade from its previous rating of Outperform. FBR believes Feraheme growth will be limited to market share gains and that Makena expectations are fully realized at current valuation levels. The firm has a $42 price target for AMAG shares.
January 21, 2015
19:55 EDTKERXKeryx 9.17M share Secondary priced at $12.00
The deal size was raised to 9.17M shares from 7.2M shares. JPMorgan acted as sole book running manager for the offering.
January 20, 2015
18:30 EDTKERXOn The Fly: After Hours Movers
Subscribe for More Information
16:06 EDTKERXKeryx files to sell $100M in common stock
J.P. Morgan is acting as the sole book-running manager in the offering. Keryx intends to use the net proceeds from the sale of its common stock to fund the ongoing commercialization and development of Auryxia in the US, pre-commercial activities in Europe, to potentially in-license, acquire and develop additional drug candidates, and other general corporate purposes.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use